The novel approach of this peptide represents a significant development in the care of the condition. Unlike existing therapies, tirzepatide impacts two pathways – glucagon-like peptide-1 (GLP-1) and the GIP hormone https://tirzepatide-peptide305421.goabroadblog.com/40727351/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment